Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh ( (AU:EBR) ) has provided an update.
EBR Systems, Inc. has received preliminary approval from the U.S. Centers for Medicare & Medicaid Services for the Transitional Pass-Through reimbursement scheme for its WiSE CRT System. This approval marks a significant milestone for EBR, as it will facilitate increased hospital adoption of their wireless cardiac pacing device in outpatient settings, providing a clear reimbursement pathway and potentially accelerating the system’s widespread adoption in the U.S. healthcare market.
The most recent analyst rating on (AU:EBR) stock is a Buy with a A$3.50 price target. To see the full list of analyst forecasts on EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh stock, see the AU:EBR Stock Forecast page.
More about EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh
Silicon Valley-based EBR Systems, Inc. is a company focused on the treatment of cardiac rhythm disease through its innovative wireless cardiac pacing technology. Their proprietary WiSE technology is designed to provide more effective cardiac stimulation by eliminating the need for traditional pacing leads, which are often associated with complications. The company’s initial product targets heart failure patients requiring Cardiac Resynchronisation Therapy (CRT) by stimulating the left ventricle without the need for coronary sinus leads.
Average Trading Volume: 997,192
For a thorough assessment of EBR stock, go to TipRanks’ Stock Analysis page.